China
· Delayed Price · Currency is CNY China Resources Sanjiu Medical & Pharmaceutical Statistics
Total Valuation
China Resources Sanjiu Medical & Pharmaceutical has a market cap or net worth of CNY 60.99 billion. The enterprise value is 60.64 billion.
| Market Cap | 60.99B |
| Enterprise Value | 60.64B |
Important Dates
The next estimated earnings date is Monday, October 28, 2024.
| Earnings Date | Oct 28, 2024 |
| Ex-Dividend Date | Jun 14, 2024 |
Share Statistics
China Resources Sanjiu Medical & Pharmaceutical has 1.28 billion shares outstanding. The number of shares has decreased by -0.24% in one year.
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -0.24% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 17.01% |
| Float | 473.74M |
Valuation Ratios
The trailing PE ratio is 18.03 and the forward PE ratio is 18.10. China Resources Sanjiu Medical & Pharmaceutical's PEG ratio is 1.21.
| PE Ratio | 18.03 |
| Forward PE | 18.10 |
| PS Ratio | 2.37 |
| PB Ratio | 3.07 |
| P/FCF Ratio | 15.27 |
| PEG Ratio | 1.21 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.95, with an EV/FCF ratio of 15.18.
| EV / Earnings | 17.97 |
| EV / Sales | 2.36 |
| EV / EBITDA | 11.95 |
| EV / EBIT | 14.25 |
| EV / FCF | 15.18 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.84 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.59 |
| Debt / FCF | 0.75 |
| Interest Coverage | 79.19 |
Financial Efficiency
Return on equity (ROE) is 15.27% and return on invested capital (ROIC) is 9.71%.
| Return on Equity (ROE) | 15.27% |
| Return on Assets (ROA) | 6.69% |
| Return on Capital (ROIC) | 9.71% |
| Revenue Per Employee | 1.26M |
| Profits Per Employee | 166,068 |
| Employee Count | 20,318 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 2.50 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.98% in the last 52 weeks. The beta is 0.37, so China Resources Sanjiu Medical & Pharmaceutical's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +3.98% |
| 50-Day Moving Average | 42.73 |
| 200-Day Moving Average | 42.72 |
| Relative Strength Index (RSI) | 59.64 |
| Average Volume (20 Days) | 16,924,317 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, China Resources Sanjiu Medical & Pharmaceutical had revenue of CNY 25.70 billion and earned 3.37 billion in profits. Earnings per share was 2.63.
| Revenue | 25.70B |
| Gross Profit | 13.72B |
| Operating Income | 4.26B |
| Pretax Income | 4.42B |
| Net Income | 3.37B |
| EBITDA | 4.99B |
| EBIT | 4.26B |
| Earnings Per Share (EPS) | 2.63 |
Balance Sheet
The company has 8.77 billion in cash and 2.99 billion in debt, giving a net cash position of 5.78 billion or 4.50 per share.
| Cash & Cash Equivalents | 8.77B |
| Total Debt | 2.99B |
| Net Cash | 5.78B |
| Net Cash Per Share | 4.50 |
| Equity (Book Value) | 25.37B |
| Book Value Per Share | 15.47 |
| Working Capital | 10.58B |
Cash Flow
In the last 12 months, operating cash flow was 4.78 billion and capital expenditures -788.19 million, giving a free cash flow of 3.99 billion.
| Operating Cash Flow | 4.78B |
| Capital Expenditures | -788.19M |
| Free Cash Flow | 3.99B |
| FCF Per Share | 3.11 |
Margins
Gross margin is 53.40%, with operating and profit margins of 16.56% and 13.13%.
| Gross Margin | 53.40% |
| Operating Margin | 16.56% |
| Pretax Margin | 17.19% |
| Profit Margin | 13.13% |
| EBITDA Margin | 19.43% |
| EBIT Margin | 16.56% |
| FCF Margin | 15.54% |
Dividends & Yields
This stock pays an annual dividend of 1.15, which amounts to a dividend yield of 2.31%.
| Dividend Per Share | 1.15 |
| Dividend Yield | 2.31% |
| Dividend Growth (YoY) | 95.00% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 45.65% |
| Buyback Yield | 0.24% |
| Shareholder Yield | 2.55% |
| Earnings Yield | 5.55% |
| FCF Yield | 6.55% |
Stock Splits
The last stock split was on June 14, 2024. It was a forward split with a ratio of 1.3.
| Last Split Date | Jun 14, 2024 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |